Disease Damage includes persistent changes in anatomy, physiology, pathology or function which result from previously active disease and from complications of therapy or other events. Changes associated with damage are often post-inflammatory, cumulative and irreversible. IMACS has developed a consensus that damage should be present at least 6 months despite prior immunosuppressive, rehabilitation or other therapies. The preliminary core set measures to assess myositis damage are provided below, with instructions and educational resources for many of the tools. Myositis Disease Damage Index (MDI)
Physician Global Assessment of Disease Damage
Patient/Parent Global Assessment of Disease Damage
Muscle Strength Testing - Manual Muscle Testing (MMT)
Functional Assessment Tools - HAQ, CHAQ
|
|